Share this article
Share this article
OXFORD, England, May 4, 2021 /PRNewswire/ Enesi Pharma ( Enesi ), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax
® technologies, announces that it has successfully developed an ImplaVax®-enabled, solid-dose recombinant H7N9 pandemic influenza vaccine and delivered proof-of-concept results in validated preclinical models.
The project
1 was conducted as part of BARDA s
Beyond the Needle initiative, which is focused on developing alternative technologies that aim to transform the paradigm of making vaccines and therapeutics easier to administer and more widely available, without the need for needles, syringes, vials, and cold-chain distribution burdens.
Honoring the Heroes of Military Medicine
HJF highlighting those involved in the fight against COVID-19.
News provided by
Share this article
Share this article
BETHESDA, Md., May 4, 2021 /PRNewswire/ The novel coronavirus, Sars-COV-2, swept across the globe in early 2020. Military, industry, private and public institutions, and individuals, all responded to the resulting COVID-19 pandemic. From donations of personal protective equipment to round-the-clock research support, the unprecedented impact on global life was met with an equally robust response. The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) honors individuals and organizations involved in this response at its annual Heroes of Military Medicine awards ceremony. With the support of the Chairman Sponsor, Health Net Federal Services, HJF recognizes individuals and organizations who have made outstanding contributions in advancing medicine for our nation s warfighters, veterans and civi
E-Mail
Scientists at the Walter Reed Army Institute for Research demonstrated that biomarkers associated with traumatic brain injury were elevated among law enforcement and military personnel, particularly in active duty participants with longer duration of service. Most notably, these elevated biomarker levels were observed in individuals without a diagnosed brain injury or concussion.
Some law enforcement and military personnel are regularly exposed to low levels of blast, particularly during training, due to the use of explosive charges and high caliber weapons. Understanding effects from these occupational exposures is a military health care priority to improve diagnosis and mitigation of ill effects.